Research Topic · Peer-Reviewed

Blood Cancer

Blood cancer, or haematological malignancy, is a group of cancers that affect the production and function of blood cells, arising in the bone marrow, blood, or lymphatic system. The principal categories are the leukaemias, which involve clonal proliferation of white-cell precursors in the marrow; the lymphomas, whic…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 20× across the literature 🔖 ISSN 3070-1937 🗓 Reviewed June 2026

Overview

Blood cancer, or haematological malignancy, is a group of cancers that affect the production and function of blood cells, arising in the bone marrow, blood, or lymphatic system. The principal categories are the leukaemias, which involve clonal proliferation of white-cell precursors in the marrow; the lymphomas, which arise from lymphocytes within lymphoid tissue; and the plasma-cell disorders, including multiple myeloma. These malignancies result from mutations and chromosomal abnormalities that disrupt normal haematopoiesis and immune function, producing anaemia, infection, bleeding, and organ involvement. Diagnosis relies on blood counts, bone-marrow examination, immunophenotyping, cytogenetics, and molecular profiling, while treatment combines chemotherapy, targeted and immune therapies, radiotherapy, and stem-cell transplantation, with extensive transfusion support. Because management depends on blood products and the correction of cytopenias, blood cancers are intimately connected with transfusion medicine. The research themes connected here engage broader cancer biology and diagnostics, including stem-cell research ethics, immunoassays and immunogenomic approaches for monitoring cancer, and biomarker-development platforms, alongside studies of cancer screening, tumour-suppressor mutations, and molecular diagnostic technologies. Across these topics, malignant transformation, immune monitoring, and diagnostic innovation recur. The journal publishes peer-reviewed clinical and laboratory studies, case reports, and reviews addressing haematological malignancies and the transfusion-relevant aspects of cancer diagnosis and treatment.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 12 articles above have been cited 20 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Blood Cancer, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Blood Transfusion (ISSN 3070-1937).

Journal editorial board
PROF OSARO ERHABOR · United Kingdom Nobu Akiyama · Japan Young-Kyun Lee · South Korea

This page summarises published research for orientation; it is not medical or professional advice.